Skip to main content
. 2017 Jan 26;18(2):260. doi: 10.3390/ijms18020260

Figure 4.

Figure 4

Overview of the (potential) clinical application of radiotracers targeting the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), somatostatin receptor (SSTR), and gastrin releasing peptide receptor (GRPR) for breast cancer imaging.* Therapy selection refers to currently clinically used hormonal and chemotherapies as discussed in this article.